We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Using an ecological momentary assessment to evaluate your digital health product.
How to create a model of how your digital health product works and choose measures for your evaluation.
How to use a micro-randomised trial to evaluate your digital health product.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
How to use feedback from marketplace reviews to evaluate your digital health product.
The guide, toolkit and further information for GB authorities with responsibility for consumer product safety.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
This report draws out incentives to social responsible business practices, reviewing how they can be encouraged
We advance prosperity by ensuring no viable UK export fails for lack of finance or insurance, doing that sustainably and at no net cost to the taxpayer.
How a marketing authorisation holder should report a defect with a veterinary medicine.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Explainer on product information templates to be used by applicants and Marketing Authorisation Holders (MAHs) of veterinary medicines.
Your purchasing strategy must show you’ve considered commercial and technology aspects, and contractual limitations.
The team capabilities available on the Digital Outcomes framework.
Papers from the Office for Product Safety and Standards.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).